Oric Pharmaceuticals, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
ORIC on Nasdaq
Location
240 E. Grand Ave., 2 Nd Floor, South San Francisco, CA

Insiders trading volume in the past year

Oric Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Pfizer Inc 10%+ Owner $46.2M Dec 23, 2022
Column Group II, Lp 10%+ Owner $30.6M Nov 12, 2021
Jacob Chacko PRESIDENT AND CEO, Director $8.01M -$204K -2.49% Jan 2, 2025
Dominic Piscitelli Chief Financial Officer $1.42M -$73.3K -4.9% Jan 2, 2025
Pratik S. Multani Chief Medical Officer $926K -$73.3K -7.33% Jan 2, 2025
Lori Anne Kunkel Director $435K Mar 3, 2025
Richard H. Scheller Director $336K May 20, 2021
Mardi Dier Director Jan 2, 2025
Richard A. Heyman Director Jan 2, 2025
Steven L. Hoerter Director Jan 2, 2025
Angie You Director Jan 2, 2025
Peter Svennilson Director, 10%+ Owner Jun 16, 2021
Carl L. Gordon Director, 10%+ Owner Jun 16, 2021

Recent Insider Transactions by Companies or Individuals for Oric Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.